Published in Clin Infect Dis on March 02, 2007
Extrapulmonary infections associated with nontuberculous mycobacteria in immunocompetent persons. Emerg Infect Dis (2009) 1.70
Clinical manifestations, diagnosis, and treatment of Mycobacterium haemophilum infections. Clin Microbiol Rev (2011) 1.13
Lymphadenitis in children is caused by Mycobacterium avium hominissuis and not related to 'bird tuberculosis'. Eur J Clin Microbiol Infect Dis (2008) 1.08
Salivary gland diseases in children. GMS Curr Top Otorhinolaryngol Head Neck Surg (2014) 0.91
Current trends in nontuberculous mycobacteria infections in Canadian children: A pediatric investigators collaborative network on infections in Canada (PICNIC) study. Paediatr Child Health (2010) 0.88
Nontuberculous Mycobacterial Disease in Children - Epidemiology, Diagnosis & Management at a Tertiary Center. PLoS One (2016) 0.88
Cervical abscess in an immunocompetent patient with Mycobacterium malmoense pulmonary disease. Oral Maxillofac Surg (2011) 0.84
Submandibular lymphadenitis caused by Mycobacterium interjectum: contribution of new diagnostic tools. Eur J Pediatr (2010) 0.83
Mycobacterium chelonae infection of the parotid gland. J Glob Infect Dis (2012) 0.81
Non-tuberculous mycobacterial infection of the parotid gland in an immunocompetent elderly patient. BMJ Case Rep (2013) 0.80
Management of lymphadenitis due to non-tuberculous mycobacterial infection in children. Pediatr Surg Int (2012) 0.79
Avian Mycobacteriosis: Still Existing Threat to Humans. Biomed Res Int (2016) 0.77
Medical Management for the Treatment of Nontuberculous Mycobacteria Infection of the Parotid Gland: Avoiding Surgery May Be Possible. Case Rep Med (2016) 0.75
Granulomatous cervicofacial lymphadenitis in children: a nine-year study in Singapore. Singapore Med J (2014) 0.75
Evidence guiding the treatment of children with mycobacterial diseases. Clin Infect Dis (2007) 0.75
Non-tuberculous mycobacterial osteomyelitis: an unusual cause of hip pain in immunocompetent children. Rheumatol Int (2009) 0.75
Facial swelling with atypical mycobacterial infection in immuno-competent patient. Indian J Otolaryngol Head Neck Surg (2011) 0.75
Noncervicofacial atypical mycobacterial lymphadenopathy in a child. Indian J Dermatol (2014) 0.75
Nontuberculous mycobacterial lymphadenitis in children. Clin Infect Dis (2007) 0.75
Anti-interferon-γ autoantibody-associated disseminated Mycobacterium abscessus infection mimicking parotid cancer with multiple metastases: A case report. Medicine (Baltimore) (2017) 0.75
Risk factors of non-tuberculous mycobacterial lymphadenitis in children: a case-control study. Eur J Pediatr (2017) 0.75
Duodenal infusion of donor feces for recurrent Clostridium difficile. N Engl J Med (2013) 20.65
Peritoneal dialysis-related infections recommendations: 2010 update. Perit Dial Int (2010) 12.06
Antibiotic treatment strategies for community-acquired pneumonia in adults. N Engl J Med (2015) 6.25
Clostridium difficile infection in Europe: a hospital-based survey. Lancet (2011) 6.25
High-throughput identification of bacteria and yeast by matrix-assisted laser desorption ionization-time of flight mass spectrometry in conventional medical microbiology laboratories. J Clin Microbiol (2010) 5.71
Peritoneal dialysis-related infections recommendations: 2005 update. Perit Dial Int (2005) 5.49
Selective digestive tract decontamination and selective oropharyngeal decontamination and antibiotic resistance in patients in intensive-care units: an open-label, clustered group-randomised, crossover study. Lancet Infect Dis (2011) 3.93
Emergence of Clostridium difficile infection due to a new hypervirulent strain, polymerase chain reaction ribotype 078. Clin Infect Dis (2008) 3.49
Cranberries vs antibiotics to prevent urinary tract infections: a randomized double-blind noninferiority trial in premenopausal women. Arch Intern Med (2011) 3.33
Lactobacilli vs antibiotics to prevent urinary tract infections: a randomized, double-blind, noninferiority trial in postmenopausal women. Arch Intern Med (2012) 3.14
Clinical implications of azole resistance in Aspergillus fumigatus, The Netherlands, 2007-2009. Emerg Infect Dis (2011) 2.84
Preventive antibiotics for infections in acute stroke: a systematic review and meta-analysis. Arch Neurol (2009) 2.55
Effect of hepatitis A vaccination programs for migrant children on the incidence of hepatitis A in The Netherlands. Eur J Public Health (2009) 2.32
Evaluation of real-time PCR and conventional diagnostic methods for the detection of Clostridium difficile-associated diarrhoea in a prospective multicentre study. J Med Microbiol (2007) 2.18
Aspergillosis due to voriconazole highly resistant Aspergillus fumigatus and recovery of genetically related resistant isolates from domiciles. Clin Infect Dis (2013) 2.09
Interpretation of Skindex-29 scores: cutoffs for mild, moderate, and severe impairment of health-related quality of life. J Invest Dermatol (2011) 2.02
Long-term therapy with tenofovir is effective for patients co-infected with human immunodeficiency virus and hepatitis B virus. Gastroenterology (2010) 1.98
An outbreak of Pneumocystis jiroveci pneumonia with 1 predominant genotype among renal transplant recipients: interhuman transmission or a common environmental source? Clin Infect Dis (2007) 1.94
Azole-resistant central nervous system aspergillosis. Clin Infect Dis (2009) 1.94
Emergence of reduced susceptibility to metronidazole in Clostridium difficile. J Antimicrob Chemother (2008) 1.91
Typing and subtyping of Clostridium difficile isolates by using multiple-locus variable-number tandem-repeat analysis. J Clin Microbiol (2006) 1.87
Population pharmacokinetics of efavirenz in an unselected cohort of HIV-1-infected individuals. Clin Pharmacokinet (2005) 1.84
Prospective multicenter evaluation of a new immunoassay and real-time PCR for rapid diagnosis of Clostridium difficile-associated diarrhea in hospitalized patients. J Clin Microbiol (2005) 1.80
Coexistence of multiple PCR-ribotype strains of Clostridium difficile in faecal samples limits epidemiological studies. J Med Microbiol (2005) 1.78
Appropriate antibiotic use for patients with urinary tract infections reduces length of hospital stay. Clin Infect Dis (2013) 1.73
Characterization of toxin A-negative, toxin B-positive Clostridium difficile isolates from outbreaks in different countries by amplified fragment length polymorphism and PCR ribotyping. J Clin Microbiol (2004) 1.73
Clostridium difficile PCR ribotype 078 toxinotype V found in diarrhoeal pigs identical to isolates from affected humans. Environ Microbiol (2009) 1.65
Trends in HIV postexposure prophylaxis prescription and compliance after sexual exposure in Amsterdam, 2000-2004. Sex Transm Dis (2007) 1.61
HIV-1 viral rebound dynamics after a single treatment interruption depends on time of initiation of highly active antiretroviral therapy. AIDS (2008) 1.56
Effects of antiretroviral therapy on semen quality. AIDS (2008) 1.54
No treatment versus 24 or 60 weeks of antiretroviral treatment during primary HIV infection: the randomized Primo-SHM trial. PLoS Med (2012) 1.52
Early versus late orbital decompression in Graves' orbitopathy: a retrospective study in 125 patients. Ophthalmology (2006) 1.51
Tuberculin skin testing is useful in the screening for nontuberculous mycobacterial cervicofacial lymphadenitis in children. Clin Infect Dis (2006) 1.49
High incidence of asymptomatic syphilis in HIV-infected MSM justifies routine screening. Sex Transm Dis (2009) 1.49
Rapid induction of multiple resistance mechanisms in Aspergillus fumigatus during azole therapy: a case study and review of the literature. Antimicrob Agents Chemother (2011) 1.49
Laboratory-acquired clostridium difficile polymerase chain reaction ribotype 027: a new risk for laboratory workers? Clin Infect Dis (2008) 1.48
Comparison of imiquimod, topical fluorouracil, and electrocautery for the treatment of anal intraepithelial neoplasia in HIV-positive men who have sex with men: an open-label, randomised controlled trial. Lancet Oncol (2013) 1.47
Assessment of upper limb capacity in children with unilateral cerebral palsy: construct validity of a Rasch-reduced Modified House Classification. Dev Med Child Neurol (2014) 1.41
Legionnaires' disease at a Dutch flower show: prognostic factors and impact of therapy. Emerg Infect Dis (2002) 1.41
Macro and micro diversity of Clostridium difficile isolates from diverse sources and geographical locations. PLoS One (2012) 1.40
A fatal pseudo-tumour: disseminated basidiobolomycosis. BMC Infect Dis (2006) 1.39
Time interval of increased risk for Clostridium difficile infection after exposure to antibiotics. J Antimicrob Chemother (2011) 1.39
Procalcitonin reflects bacteremia and bacterial load in urosepsis syndrome: a prospective observational study. Crit Care (2010) 1.38
Detection of a point mutation associated with high-level isoniazid resistance in Mycobacterium tuberculosis by using real-time PCR technology with 3'-minor groove binder-DNA probes. J Clin Microbiol (2003) 1.37
All-cause and disease-specific mortality in hospitalized patients with Clostridium difficile infection: a multicenter cohort study. Clin Infect Dis (2013) 1.26
Adaptation of HIV-1 envelope gp120 to humoral immunity at a population level. Nat Med (2010) 1.26
High prevalence of sexually transmitted infections in HIV-infected men during routine outpatient visits in the Netherlands. Sex Transm Dis (2012) 1.25
Electronic monitoring-based counseling to enhance adherence among HIV-infected patients: a randomized controlled trial. Health Psychol (2010) 1.24
Effectiveness of early switch from intravenous to oral antibiotics in severe community acquired pneumonia: multicentre randomised trial. BMJ (2006) 1.22
Cervicofacial lymphadenitis in children caused by Mycobacterium haemophilum. Clin Infect Dis (2005) 1.21
Viral load levels measured at set-point have risen over the last decade of the HIV epidemic in the Netherlands. PLoS One (2009) 1.20
Cellular levels of HIV unspliced RNA from patients on combination antiretroviral therapy with undetectable plasma viremia predict the therapy outcome. PLoS One (2009) 1.16
Clinical, immunological and virological response to different antiretroviral regimens in a cohort of HIV-2-infected patients. AIDS (2003) 1.15
Lack of value of routine analysis of cerebrospinal fluid for prediction and diagnosis of external drainage-related bacterial meningitis. J Neurosurg (2006) 1.13
Modest nonadherence to antiretroviral therapy promotes residual HIV-1 replication in the absence of virological rebound in plasma. J Infect Dis (2012) 1.13
Clinical manifestations, diagnosis, and treatment of Mycobacterium haemophilum infections. Clin Microbiol Rev (2011) 1.13
Activity of broadly neutralizing antibodies, including PG9, PG16, and VRC01, against recently transmitted subtype B HIV-1 variants from early and late in the epidemic. J Virol (2011) 1.13
Comparative analysis of an expanded Clostridium difficile reference strain collection reveals genetic diversity and evolution through six lineages. Infect Genet Evol (2012) 1.12
Assessing children's competence to consent in research by a standardized tool: a validity study. BMC Pediatr (2012) 1.11
Nelfinavir plasma concentrations are low during pregnancy. Clin Infect Dis (2004) 1.11
Clinical experience with the combined use of lopinavir/ritonavir and rifampicin. AIDS (2009) 1.11
Health-related quality of life assessment in dermatology: interpretation of Skindex-29 scores using patient-based anchors. J Invest Dermatol (2009) 1.09
Mycobacterium haemophilum and lymphadenitis in children. Emerg Infect Dis (2005) 1.07
Restoration of the CD4 T cell compartment after long-term highly active antiretroviral therapy without phenotypical signs of accelerated immunological aging. J Immunol (2008) 1.07
HIV-1 dual infection is associated with faster CD4+ T-cell decline in a cohort of men with primary HIV infection. Clin Infect Dis (2011) 1.07
Typing Clostridium difficile strains based on tandem repeat sequences. BMC Microbiol (2009) 1.06
Analysis of the effect of highly active antiretroviral therapy during acute HIV-1 infection on HIV-specific CD4 T cell functions. AIDS (2005) 1.06
P glycoprotein in human immunodeficiency virus type 1 infection and therapy. Antimicrob Agents Chemother (2004) 1.06
Self-reported adherence is more predictive of virological treatment response among patients with a lower tendency towards socially desirable responding. Antivir Ther (2010) 1.05
Clostridium difficile: controversies and approaches to management. Curr Opin Infect Dis (2009) 1.04
Stable concentrations of zidovudine, stavudine, lamivudine, abacavir, and nevirapine in serum and cerebrospinal fluid during 2 years of therapy. Antimicrob Agents Chemother (2002) 1.04
Decreased effectiveness of metronidazole for the treatment of Clostridium difficile infection? Clin Infect Dis (2008) 1.03
TcdC does not significantly repress toxin expression in Clostridium difficile 630ΔErm. PLoS One (2012) 1.02
Bacterial meningitis caused by the use of ventricular or lumbar cerebrospinal fluid catheters. J Neurosurg (2005) 1.02
High prevalence of reduced bone mineral density in primary HIV-1-infected men. AIDS (2010) 1.02
Long-term symptom recovery and health-related quality of life in patients with mild-to-moderate-severe community-acquired pneumonia. Chest (2006) 1.02
Transient lowering of the viral set point after temporary antiretroviral therapy of primary HIV type 1 infection. AIDS Res Hum Retroviruses (2010) 1.02
HIV stigma and depressive symptoms are related to adherence and virological response to antiretroviral treatment among immigrant and indigenous HIV infected patients. AIDS Behav (2012) 1.01
Antibiotics and steroids for exacerbations of COPD in primary care: compliance with Dutch guidelines. Br J Gen Pract (2006) 1.01
Preventive antibiotics in stroke study: rationale and protocol for a randomised trial. Int J Stroke (2010) 1.01
Antibiotics in pandemic flu. BMJ (2006) 1.00
Declining trend in transmission of drug-resistant HIV-1 in Amsterdam. AIDS (2004) 1.00
HPV and anal cancer in HIV-infected individuals: a review. Curr HIV/AIDS Rep (2014) 1.00
Risk factors for bacteremia with uropathogen not cultured from urine in adults with febrile urinary tract infection. Clin Infect Dis (2010) 1.00
The Academic Medical Center Linear Disability Score (ALDS) item bank: item response theory analysis in a mixed patient population. Health Qual Life Outcomes (2005) 1.00
Bovine antibody-enriched whey to aid in the prevention of a relapse of Clostridium difficile-associated diarrhoea: preclinical and preliminary clinical data. J Med Microbiol (2005) 0.99
HIV status disclosure among HIV-positive African and Afro-Caribbean people in the Netherlands. AIDS Care (2011) 0.99
Appropriateness of empirical treatment and outcome in bacteremia caused by extended-spectrum-β-lactamase-producing bacteria. Antimicrob Agents Chemother (2013) 0.99
Nutritional goals, prescription and delivery in a pediatric intensive care unit. Clin Nutr (2008) 0.99
Duration of antibiotic therapy for cholangitis after successful endoscopic drainage of the biliary tract. Gastrointest Endosc (2002) 0.98
Oral bacteria and yeasts in relationship to oral ulcerations in hematopoietic stem cell transplant recipients. Support Care Cancer (2012) 0.98
C. difficile 630Δerm Spo0A regulates sporulation, but does not contribute to toxin production, by direct high-affinity binding to target DNA. PLoS One (2012) 0.98
Inter-laboratory comparison of three different real-time PCR assays for the detection of Pneumocystis jiroveci in bronchoalveolar lavage fluid samples. J Med Microbiol (2006) 0.98